Command Palette

Search for a command to run...

VENUSREM
450.65(-2.12%)
1W: +4.62%

Venus Remedies Peer Comparison

Snapshot Summary

Venus Remedies Ltd. presents a competitive valuation and solid growth metrics compared to its peers in the pharmaceuticals sector. While it has the lowest PE ratio along with strong cash flow metrics, some peers exhibit better profitability and growth. Companies like Mankind Pharma and Dr. Reddy's demonstrate superior growth, while Divi's Laboratories stands out for its profitability despite a high PE ratio.

  • Venus Remedies shows strong cash flow metrics with a debt-equity ratio of 0.003.
  • Lowest PE ratio among peers, indicating potential undervaluation.
  • Mankind Pharma and Dr. Reddy's Laboratories exhibit the highest growth metrics.
  • Dr. Reddy's Laboratories Ltd.: Best profitability with high ROE and strong growth metrics.
  • Mankind Pharma Ltd.: Highest revenue growth YoY and over the past three years, showcasing strong market performance.
  • Cipla Ltd.: Solid profitability metrics and reasonable valuation ratios.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
VENUSREM₹460.55₹615.62Cr11.7113.17%0.00
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.